Gateway's sale of Healthway Medical notes to third parties raises eyebrows
Singapore
AHEAD of Healthway Medical Corporation's (HMC) extraordinary general meeting (EGM) to vote on the second tranche of S$60 million convertible notes, some minority shareholders have raised concerns whether private-equity fund Gateway Partners is there to make a quick buck at their expense.
Questions have risen over why Gateway chose to sell its first tranche of S$10 million in convertible notes to third parties after Lippo-linked Gentle Care has made an offer to buy over these notes at the same price it is offering to pay for each share of HMC.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Asean+3 has made strong progress on cross-border payment connectivity, but more work lies ahead
Indonesia targets year-end start for US$30 billion clean power exports to Singapore
Seatrium surge leads Singapore stocks slightly higher on Tuesday; STI up 0.1%